Sentence examples for formulated product from inspiring English sources

In addition to process design and optimization which are the major concerns of commodity production, the specialty and formulated product industries face also new technical as well as marketing challenges (time to market, smart product design, choice or adaptation of generic, not dedicated plants etc).

Among the limitations of this vaccine are potential virus escape from the production facility, short shelf life of formulated product, short duration of immunity and requirement of dozens of antigens to address viral antigenic diversity.

In this chapter, we present the tools that can be used to address formulated product design.

"If you have maximum amounts and reduce the sugar or salt in the formulated product then people can choose if they want to sprinkle some on top – they are conscious of what they are doing – whereas if it's in the formulated product it's much harder to control," said Burnham.

Vitamin Shoppe appears no longer to be stocking Jack3d, and now offers only Jack3d Micro, a newly formulated product that does not contain DMAA.

Various types of data, methods and tools are needed to tackle formulated product design problems to achieve an optimal design.

The rate and extent of absorption of class II compounds is highly dependent on the performance of the formulated product.

When designing/verifying a formulated product, the required modelling effort is challenging as properties and functions of complex mixtures need to be predicted.

In Africa, their introduction on a wide scale began in 2003 and currently most African countries have adopted or are using ACTs as first or second line treatments, either artesunate-amodiaquine or artemether-lumefantrine (AL) [2], available as co-formulations produced under GMP, though the former is also used as a co-blistered or non-co-formulated product.

Between 10 24% of individuals with ORS consulted a health care provider., A re-formulated product for 2001 2002 (using a second virus splitting detergent) was shown to cause mild ORS at a rate of 2.9% among vaccinated adults.

The fixed-dose co-formulated product (manufactured by Creapharm, France, batch no. CPM 5856) consisted of 100 mg AS and 270 mg AQ base; the loose non-fixed product consisted of AS (Arsumax 50 mg tablets; Sanofi-Aventis, Paris, France/Guilin Pharma Co, China, batch no. 31201) and AQ (Flavoquin 153 mg of AQ base; Hoechst Marion Roussel, Sanofi-Aventis, batch no. 4).